| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2206-Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | Y | 1 Tissue for MammaPrint testing | 960 | 1215 | 525 | 243 | 119 | 41 | 10 | 11/27/2023 | 391 | 128 |
| 1215 | 525 | 243 | 119 | 41 | 10 | |||||||||
| 2 | Y | 2 SOC Chemotherapy | 210 | 90 | 37 | 15 | 4 | 1 | 11/27/2023 | |||||
| 3 SOC Chemotherapy + Durvalumab | 206 | 90 | 35 | 15 | 5 | 0 | ||||||||
| 416 | 180 | 72 | 30 | 9 | 1 | |||||||||
| S2212-Breast, TNBC, Neoadj Chemo + Pembro | 1 | Y | 1 Carbo + Paclitaxel + Pembro -> AC + Pembro | 2400 | 850 | 405 | 209 | 104 | 35 | 2 | 09/15/2023 | 450 | 162 | |
| 2 Carbo + Docetaxel + Pembro | 849 | 399 | 210 | 103 | 34 | 6 | ||||||||
| 1699 | 804 | 419 | 207 | 69 | 8 | |||||||||
| Yes | A011801-BRST, HER2+, T-DM1+Placebo v T-DM1+Tucatinib | 1 | E | Total Registrations | 55 | 0 | 0 | 0 | 0 | 0 | 03/11/2021 | 463 | 190 | |
| 55 | 0 | 0 | 0 | 0 | 0 | |||||||||
| A012103-Breast,StgT1cN1-2/T2-4N0-2,obsvsPembrolizumab | 1 | E | Total Registrations | 67 | 29 | 15 | 11 | 1 | 1 | 08/24/2023 | 438 | 184 | ||
| 67 | 29 | 15 | 11 | 1 | 1 | |||||||||
| NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA | 1 | T | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/22/2017 | ||||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| NRGBR005-Br, Stg II&IIIA, Post NAdj Chemo Br Conserv | 1 | T | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 06/22/2018 | ||||
| 7 | 0 | 0 | 0 | 0 | 0 | |||||||||
| No | A012303-Breast, HER2+, Shortened Adj | 1 | E | Total Registrations | 5 | 5 | 4 | 1 | 0 | 0 | 03/06/2026 | 79 | 32 | |
| 5 | 5 | 4 | 1 | 0 | 0 | |||||||||
| NRGBR009-Breast, EarlyStg, Adjuvant Chemo | 1 | E | Total Registrations | 68 | 48 | 22 | 14 | 2 | 0 | 01/31/2024 | 520 | 197 | ||
| 68 | 48 | 22 | 14 | 2 | 0 | |||||||||
| 2 | E | Total Registrations | 49 | 30 | 11 | 5 | 1 | 0 | 01/31/2024 | |||||
| 49 | 30 | 11 | 5 | 1 | 0 | |||||||||
| Study | Registration/Phase | Open Date | # of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|
| S2511 Brst, de novo StgIV oligo, locoreg tx vs SOC | 1 Initial Registration | 18-Aug-26 | 42 | 13 |
| 2 Cohort Assignment/Randomization | 18-Aug-26 | 42 | 13 |